Neuregulin in neuron/glial interactions in the central nervous system

GGF2 diminishes autoimmune demyelination, promotes oligodendrocyte progenitor expansion, and enhances remyelination

M. A. Marchionni, B. Cannella, C. Hoban, Y. L. Gao, R. Garcia-Arenas, D. Lawson, E. Happel, F. Noel, P. Tofilon, D. Gwynne, C. S. Raine

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Glial growth factor 2 (GGF2) is a neuronal signal that promotes the proliferation and survival of the oligodendrocyte, the myelinating cell of the central nervous system (CNS). This study has focused on recombinant human GGF2 (rhGGF2) and it's potential to affect clinical recovery and repair to damaged myelin in chronic relapsing experimental autoimmune encephalomyelitis (EAE) in the mouse, a major animal model for the human demyelinating disease, multiple sclerosis (MS). Mice, with EAE were treated with rhGGF2 during both the acute and relapsing phases, and GGF2 treatment led to delayed signs, decreased severity and resulted in statistically significant reductions in relapse rate. Further, rhGGF2-treated groups displayed CNS lesions with more remyelination than in controls. This correlated with increased expression of myelin basic protein exon 2, a marker for remyelination, and with an increase of the regulatory cytokine, IL-10. Thus, a beneficial effect of a neurotrophic growth factor has been demonstrated upon the clinical, pathologic and molecular manifestations of autoimmune demyelination, an effect that was associated with increased expression of a Th2 cytokine, rhGGF2 treatment may represent a novel approach to the treatment of MS (Cannella et al., 1998).

Original languageEnglish (US)
Pages (from-to)283-295
Number of pages13
JournalAdvances in Experimental Medicine and Biology
Volume468
StatePublished - 2000
Externally publishedYes

Fingerprint

Neuregulins
Neuregulin-1
Oligodendroglia
Neurology
Demyelinating Diseases
Neuroglia
Neurons
Central Nervous System
Autoimmune Experimental Encephalomyelitis
Cytokines
Myelin Basic Protein
Multiple Sclerosis
Interleukin-10
Exons
Intercellular Signaling Peptides and Proteins
Animals
Repair
Nerve Growth Factors
Recovery
Myelin Sheath

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Neuregulin in neuron/glial interactions in the central nervous system : GGF2 diminishes autoimmune demyelination, promotes oligodendrocyte progenitor expansion, and enhances remyelination. / Marchionni, M. A.; Cannella, B.; Hoban, C.; Gao, Y. L.; Garcia-Arenas, R.; Lawson, D.; Happel, E.; Noel, F.; Tofilon, P.; Gwynne, D.; Raine, C. S.

In: Advances in Experimental Medicine and Biology, Vol. 468, 2000, p. 283-295.

Research output: Contribution to journalArticle

Marchionni, MA, Cannella, B, Hoban, C, Gao, YL, Garcia-Arenas, R, Lawson, D, Happel, E, Noel, F, Tofilon, P, Gwynne, D & Raine, CS 2000, 'Neuregulin in neuron/glial interactions in the central nervous system: GGF2 diminishes autoimmune demyelination, promotes oligodendrocyte progenitor expansion, and enhances remyelination', Advances in Experimental Medicine and Biology, vol. 468, pp. 283-295.
Marchionni, M. A. ; Cannella, B. ; Hoban, C. ; Gao, Y. L. ; Garcia-Arenas, R. ; Lawson, D. ; Happel, E. ; Noel, F. ; Tofilon, P. ; Gwynne, D. ; Raine, C. S. / Neuregulin in neuron/glial interactions in the central nervous system : GGF2 diminishes autoimmune demyelination, promotes oligodendrocyte progenitor expansion, and enhances remyelination. In: Advances in Experimental Medicine and Biology. 2000 ; Vol. 468. pp. 283-295.
@article{87f4ada6ba9f4b128c09b4cd8de55376,
title = "Neuregulin in neuron/glial interactions in the central nervous system: GGF2 diminishes autoimmune demyelination, promotes oligodendrocyte progenitor expansion, and enhances remyelination",
abstract = "Glial growth factor 2 (GGF2) is a neuronal signal that promotes the proliferation and survival of the oligodendrocyte, the myelinating cell of the central nervous system (CNS). This study has focused on recombinant human GGF2 (rhGGF2) and it's potential to affect clinical recovery and repair to damaged myelin in chronic relapsing experimental autoimmune encephalomyelitis (EAE) in the mouse, a major animal model for the human demyelinating disease, multiple sclerosis (MS). Mice, with EAE were treated with rhGGF2 during both the acute and relapsing phases, and GGF2 treatment led to delayed signs, decreased severity and resulted in statistically significant reductions in relapse rate. Further, rhGGF2-treated groups displayed CNS lesions with more remyelination than in controls. This correlated with increased expression of myelin basic protein exon 2, a marker for remyelination, and with an increase of the regulatory cytokine, IL-10. Thus, a beneficial effect of a neurotrophic growth factor has been demonstrated upon the clinical, pathologic and molecular manifestations of autoimmune demyelination, an effect that was associated with increased expression of a Th2 cytokine, rhGGF2 treatment may represent a novel approach to the treatment of MS (Cannella et al., 1998).",
author = "Marchionni, {M. A.} and B. Cannella and C. Hoban and Gao, {Y. L.} and R. Garcia-Arenas and D. Lawson and E. Happel and F. Noel and P. Tofilon and D. Gwynne and Raine, {C. S.}",
year = "2000",
language = "English (US)",
volume = "468",
pages = "283--295",
journal = "Advances in Experimental Medicine and Biology",
issn = "0065-2598",
publisher = "Springer New York",

}

TY - JOUR

T1 - Neuregulin in neuron/glial interactions in the central nervous system

T2 - GGF2 diminishes autoimmune demyelination, promotes oligodendrocyte progenitor expansion, and enhances remyelination

AU - Marchionni, M. A.

AU - Cannella, B.

AU - Hoban, C.

AU - Gao, Y. L.

AU - Garcia-Arenas, R.

AU - Lawson, D.

AU - Happel, E.

AU - Noel, F.

AU - Tofilon, P.

AU - Gwynne, D.

AU - Raine, C. S.

PY - 2000

Y1 - 2000

N2 - Glial growth factor 2 (GGF2) is a neuronal signal that promotes the proliferation and survival of the oligodendrocyte, the myelinating cell of the central nervous system (CNS). This study has focused on recombinant human GGF2 (rhGGF2) and it's potential to affect clinical recovery and repair to damaged myelin in chronic relapsing experimental autoimmune encephalomyelitis (EAE) in the mouse, a major animal model for the human demyelinating disease, multiple sclerosis (MS). Mice, with EAE were treated with rhGGF2 during both the acute and relapsing phases, and GGF2 treatment led to delayed signs, decreased severity and resulted in statistically significant reductions in relapse rate. Further, rhGGF2-treated groups displayed CNS lesions with more remyelination than in controls. This correlated with increased expression of myelin basic protein exon 2, a marker for remyelination, and with an increase of the regulatory cytokine, IL-10. Thus, a beneficial effect of a neurotrophic growth factor has been demonstrated upon the clinical, pathologic and molecular manifestations of autoimmune demyelination, an effect that was associated with increased expression of a Th2 cytokine, rhGGF2 treatment may represent a novel approach to the treatment of MS (Cannella et al., 1998).

AB - Glial growth factor 2 (GGF2) is a neuronal signal that promotes the proliferation and survival of the oligodendrocyte, the myelinating cell of the central nervous system (CNS). This study has focused on recombinant human GGF2 (rhGGF2) and it's potential to affect clinical recovery and repair to damaged myelin in chronic relapsing experimental autoimmune encephalomyelitis (EAE) in the mouse, a major animal model for the human demyelinating disease, multiple sclerosis (MS). Mice, with EAE were treated with rhGGF2 during both the acute and relapsing phases, and GGF2 treatment led to delayed signs, decreased severity and resulted in statistically significant reductions in relapse rate. Further, rhGGF2-treated groups displayed CNS lesions with more remyelination than in controls. This correlated with increased expression of myelin basic protein exon 2, a marker for remyelination, and with an increase of the regulatory cytokine, IL-10. Thus, a beneficial effect of a neurotrophic growth factor has been demonstrated upon the clinical, pathologic and molecular manifestations of autoimmune demyelination, an effect that was associated with increased expression of a Th2 cytokine, rhGGF2 treatment may represent a novel approach to the treatment of MS (Cannella et al., 1998).

UR - http://www.scopus.com/inward/record.url?scp=0034466119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034466119&partnerID=8YFLogxK

M3 - Article

VL - 468

SP - 283

EP - 295

JO - Advances in Experimental Medicine and Biology

JF - Advances in Experimental Medicine and Biology

SN - 0065-2598

ER -